deltatrials
Unknown PHASE3 INTERVENTIONAL NCT00410631

Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma

NB2004 Trial Protocol for Risk Adapted Treatment of Children With Neuroblastoma

Sponsor: German Society for Pediatric Oncology and Hematology GPOH gGmbH

Conditions Neuroblastoma
Interventions autologous hematopoietic stem cell transplantation carboplatin cisplatin conventional surgery cyclophosphamide dacarbazine doxorubicin hydrochloride etoposide phosphate filgrastim ifosfamide iobenguane I 131 isotretinoin melphalan peripheral blood stem cell transplantation radiation therapy topotecan hydrochloride vincristine sulfate vindesine
Updated 7 times since 2017 Last updated: Aug 6, 2013 Started: Oct 31, 2004 Primary completion: Dec 31, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Neuroblastoma and is currently ongoing. German Society for Pediatric Oncology and Hematology GPOH gGmbH leads this study, which shows 7 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Aug 2023 · 31 months · monthly snapshotUnknown Status~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 12 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  4. Aug 2023 — Jul 2024 [monthly]

    Unknown Status PHASE3

  5. Jan 2021 — Aug 2023 [monthly]

    Unknown Status PHASE3

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • German Society for Pediatric Oncology and Hematology GPOH gGmbH
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aachen, Germany , Aarau, Switzerland , Augsburg, Germany , Bamberg, Germany , Basel, Switzerland , Bayreuth, Germany , Berlin, Germany , Biefeld, Germany , Bonn, Germany , Braunschweig, Germany and 60 more locations